BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12931660)

  • 21. Copper-64-Labeled Antibody Fragments for Immuno-PET/Radioimmunotherapy with Low Renal Radioactivity Levels and Amplified Tumor-Kidney Ratios.
    Suzuki H; Kise S; Kaizuka Y; Watanabe R; Sugawa T; Furukawa T; Fujii H; Uehara T
    ACS Omega; 2021 Aug; 6(33):21556-21562. PubMed ID: 34471758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal brush border strategy: A developing procedure to reduce renal radioactivity levels of radiolabeled polypeptides.
    Arano Y
    Nucl Med Biol; 2021 Jan; 92():149-155. PubMed ID: 32169305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel immunoscintigraphy technique using metabolizable linker with angiotensin II treatment.
    Nakamoto Y; Sakahara H; Saga T; Sato N; Zhao S; Arano Y; Fujioka Y; Saji H; Konishi J
    Br J Cancer; 1999 Apr; 79(11-12):1794-9. PubMed ID: 10206295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives.
    Behr TM; Sharkey RM; Juweid ME; Blumenthal RD; Dunn RM; Griffiths GL; Bair HJ; Wolf FG; Becker WS; Goldenberg DM
    Cancer Res; 1995 Sep; 55(17):3825-34. PubMed ID: 7641200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
    Temponi M; Gold AM; Ferrone S
    Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential inhibitory effect of L-lysine on renal accumulation of 67Cu-labelled F(ab')2 fragments in mice.
    Rutherford RA; Smith A; Waibel R; Schubiger PA
    Int J Cancer; 1997 Jul; 72(3):522-9. PubMed ID: 9247299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.
    Buchegger F; Haskell CM; Schreyer M; Scazziga BR; Randin S; Carrel S; Mach JP
    J Exp Med; 1983 Aug; 158(2):413-27. PubMed ID: 6886623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry.
    Behr TM; Sharkey RM; Sgouros G; Blumenthal RD; Dunn RM; Kolbert K; Griffiths GL; Siegel JA; Becker WS; Goldenberg DM
    Cancer; 1997 Dec; 80(12 Suppl):2591-610. PubMed ID: 9406714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced tumor localization of radiolabeled Fab fragments of monoclonal antibody A7 in nude mice bearing human pancreatic carcinoma xenografts.
    Otsuji E; Yamaguchi T; Yamaoka N; Kato M; Kotani T; Kitamura K; Yamaguchi N; Takahashi T
    Jpn J Cancer Res; 1993 Aug; 84(8):914-20. PubMed ID: 8407556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations.
    Behr TM; Goldenberg DM; Becker W
    Eur J Nucl Med; 1998 Feb; 25(2):201-12. PubMed ID: 9473271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo.
    Rogers BE; Franano FN; Duncan JR; Edwards WB; Anderson CJ; Connett JM; Welch MJ
    Cancer Res; 1995 Dec; 55(23 Suppl):5714s-5720s. PubMed ID: 7493333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-lysine effectively blocks renal uptake of 125I- or 99mTc-labeled anti-Tac disulfide-stabilized Fv fragment.
    Kobayashi H; Yoo TM; Kim IS; Kim MK; Le N; Webber KO; Pastan I; Paik CH; Eckelman WC; Carrasquillo JA
    Cancer Res; 1996 Aug; 56(16):3788-95. PubMed ID: 8706025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiolabeled monoclonal antibody 15 and its fragments for localization and imaging of xenografts of human lung cancer.
    Endo K; Kamma H; Ogata T
    J Natl Cancer Inst; 1988 Aug; 80(11):835-42. PubMed ID: 3392743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanoma localization in nude mice with monoclonal Fab against p97.
    Beaumier PL; Krohn KA; Carrasquillo JA; Eary J; Hellström I; Hellström KE; Nelp WB; Larson SM
    J Nucl Med; 1985 Oct; 26(10):1172-9. PubMed ID: 4045562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide linkers lead to modification of liver metabolism and improved tumor targeting of copper-67-labeled antibody fragments.
    Novak-Hofer I; Zimmermann K; Schubiger PA
    Cancer Biother Radiopharm; 2001 Dec; 16(6):469-81. PubMed ID: 11789024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Streptavidin in antibody pretargeting. 2. Evaluation Of methods for decreasing localization of streptavidin to kidney while retaining its tumor binding capacity.
    Wilbur DS; Hamlin DK; Buhler KR; Pathare PM; Vessella RL; Stayton PS; To R
    Bioconjug Chem; 1998; 9(3):322-30. PubMed ID: 9576806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose.
    Förster GJ; Santos EB; Smith-Jones PM; Zanzonico P; Larson SM
    J Nucl Med; 2006 Jan; 47(1):140-9. PubMed ID: 16391198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal metabolism of 111In-DTPA-D-Phe1-octreotide in vivo.
    Akizawa H; Arano Y; Uezono T; Ono M; Fujioka Y; Uehara T; Yokoyama A; Akaji K; Kiso Y; Koizumi M; Saji H
    Bioconjug Chem; 1998; 9(6):662-70. PubMed ID: 9815158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiolations, 99mTc labelings, and animal in vivo biodistributions of divalent monoclonal antibody fragments.
    Govindan SV; Goldenberg DM; Grebenau RC; Hansen HJ; Griffiths GL
    Bioconjug Chem; 1996; 7(3):290-7. PubMed ID: 8816950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.